Form D · Biotechnology
On-Q-ity, Inc.
Waltham, MA · CIK 0001543182
Offering snapshot reported Feb 28, 2012 · SEC filing
- Reported sold
- $2.5M Offering amount: $6.53M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 14, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 28, 2012 | Initial | $2,500,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-174063
Series B Preferred Stock
Source: Form D, filed Feb 28, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bruce Booth | Director |
| Robert S. Epstein | Director |
| Stephen Kraus | Director |
| Dion Madsen | Director |
| Sue Siegel | Director |
| Michael T. Stocum | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
610 Lincoln Street, 3 Rd Floor North Building
Waltham, MA, 02451
Waltham, MA, 02451